Testosterone insufficiency in human immunodeficiency virus (HIV) infected women

Testosterone insufficiency in human immunodeficiency virus (HIV) infected women - TI-study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32221

Enrollment

Registered

2007-11-13

Start date

2007-11-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mogelijke insufficientie van testosteron bij HIV infectie testosterone deficiency among HIV infected women

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Female HIV-infected At least 18 year of age Able and willing to provide informed consent Understanding of Dutch or English language

Exclusion criteria

Exclusion criteria: Androgen therapy during the 6 months prior to study start Lactation and/or pregnancy in the 6 months prior to study start Thyroid disease; hypo * or hyperthyroidism Inability to understand questionnaire Transgender hormonal/surgical therapies in past Ovariectomy or radiation of the ovaries

Design outcomes

Primary

Measure	Time frame
Hormones: testosteron and SHBG	—

Secondary

Measure	Time frame
Questionnaires: FSFI, FSDS, SF36/MFI-20, SCL-90.	—

Countries

Netherlands

Outcome results